GTI Resources reports uranium and vanadium assays

|

Published 19-MAY-2021 14:16 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

GTI Resources Ltd (ASX:GTR) has reported eU3O8 downhole gamma assay results from Section 36 which is part of the overall Henry Mountains Uranium and Vanadium Project in Utah.

Initial uranium exploration of Section 36 (adjacent to and along strike from to the Jeffrey Project) was completed, including geological mapping, mapping of all existing underground adits and geophysical downhole logging of 56 existing drill holes.

Hole 36‐14 contained 1.5 metres from 41 feet at a grade of 0.19% eU3O8 (1,900 ppm).

Within this zone the best interval was one metre at a grade of 0.26% eU3O8 (2,600 ppm).

Over half of drill holes showed at least trace U3O8 mineralisation to a maximum depth of 61 feet.

The thickness and grade of uranium mineralisation was consistent with that observed in the region’s past producing mines that produced in excess of 17.5Mt @ 2,400ppm U3O8 (92 mlbs U3O8) and 12,500 ppm V2O5 (482 mlbs V2O5).

Management opts for more effective and efficient surface drilling

The next phase of uranium exploration includes surface drilling of up to 40 holes and the geophysical logging of an additional 39 existing small diameter drillholes.

The company’s previously planned uranium exploration approach included underground drilling from the principal existing underground mines, namely the East and West mines.

Pending approvals and the confirmation of contractor availability, further drilling is planned for July.

After completion of a more extensive survey of the site and geophysical downhole logging of existing drillholes, it has become apparent that surface drilling is a substantially more effective and efficient method to extend the area of known mineralisation.

Using information gathered from the downhole geophysical logging program and geologic mapping, a surface drilling program is now proposed within the exploration areas shown below.

Uranium mineral resource planned for section 36

Pending results of the planned drilling campaign, the company is targeting development of a JORC code compliant uranium mineral resource for Section 36 and other areas within the Henry Mountain Uranium and Vanadium Project.

The shallow nature of the mineralisation supports continued low‐cost, rapid exploration advancements.

As shown below, the company has approximately 1500 hectares of landholdings in the Henry Mountains region of Utah, within Garfield and Wayne Counties.

The region forms part of the prolific Colorado Plateau uranium province that historically provided the most important uranium resources in the US.

Sandstone-hosted ores have been mined in the region since 1904.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X